Folinic acid and peripheral blood stem cell collection in patients with acute leukemia

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial.

Leukemia·2017

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

[Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].

La Revue de medecine interne·2015

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.

Bone marrow transplantation·2014

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

Leukemia·2013

Minor clone provides a reservoir for relapse in multiple myeloma.

Leukemia·2012

Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

British journal of haematology·2026

Carrying a crisis: The risk of a painful sickle cell crisis during pregnancy.

British journal of haematology·2026

Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

British journal of haematology·2026

Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification-Insights from chromosome count and cytogenetic abnormalities.

British journal of haematology·2026

A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

British journal of haematology·2026

Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel-like factor 1 (KLF-1)-E325K-associated congenital dyserythropoietic anaemia (CDA-IV).

British journal of haematology·2026

Rhomboid protease RHBDL2 is a calcium-activated suppressor of EGFR signalling in keratinocytes.

Cellular and molecular life sciences : CMLS·2026

The Role of Ferroptosis Induced by Iron Overload in Osteoblast and Osteoclast Function.

Cell biology international·2026

Comparison of Uncovered and Covered Biliary SEMS for the Salvage of Obstructed SEMS: A Multicenter Retrospective Propensity Score-Weighted Study.

Journal of gastroenterology and hepatology·2026

Therapeutic Effects of WIN55,212-2 on Temporomandibular Joint Osteoarthritis in a Rat Model and Primary Temporomandibular Joint Condylar Chondrocytes.

Current medicinal chemistry·2026

Novel glutaminase-free l-asparaginase from Leuconostoc mesenteroides BN1: biochemical properties, molecular dynamics, and anticancer activity.

RSC advances·2026

Exploring Thyrotoxic Hypercalcaemia Through Two Cases: A Myriad of Uncertainties.

Case reports in endocrinology·2026

Related Experiment Videos

Folinic acid and peripheral blood stem cell collection in patients with acute leukemia

Related Concept Videos

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial.

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma.

[Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

Minor clone provides a reservoir for relapse in multiple myeloma.

Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

Carrying a crisis: The risk of a painful sickle cell crisis during pregnancy.

Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification-Insights from chromosome count and cytogenetic abnormalities.

A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel-like factor 1 (KLF-1)-E325K-associated congenital dyserythropoietic anaemia (CDA-IV).

Rhomboid protease RHBDL2 is a calcium-activated suppressor of EGFR signalling in keratinocytes.

The Role of Ferroptosis Induced by Iron Overload in Osteoblast and Osteoclast Function.

Comparison of Uncovered and Covered Biliary SEMS for the Salvage of Obstructed SEMS: A Multicenter Retrospective Propensity Score-Weighted Study.

Therapeutic Effects of WIN55,212-2 on Temporomandibular Joint Osteoarthritis in a Rat Model and Primary Temporomandibular Joint Condylar Chondrocytes.

Novel glutaminase-free l-asparaginase from Leuconostoc mesenteroides BN1: biochemical properties, molecular dynamics, and anticancer activity.

Exploring Thyrotoxic Hypercalcaemia Through Two Cases: A Myriad of Uncertainties.

Related Experiment Videos

Folinic acid and peripheral blood stem cell collection in patients with acute leukemia

Related Concept Videos

Related Articles